ArticleJournal for immunotherapy of cancer2020

Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma.

Jacob L Goldberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.